Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data
Bio Expo
Champignondagen
  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
ClearNote Health
  • Press Releases

ClearNote Health Launches Enhanced Avantect® Pancreatic Cancer Test

  • The Pharma Data
  • February 24, 2026

ClearNote Health Enhances Early Detection of Pancreatic Cancer with New Avantect® Test Why is early detection of pancreatic cancer so critical? ClearNote Health, a company dedicated to improving early detection…

Read MoreClearNote Health Launches Enhanced Avantect® Pancreatic Cancer Test
Gossamer
  • BusinessResearch

Gossamer Bio Announces Topline Results for Phase 3 PROSERA Study of Seralutinib in PAH

  • The Pharma Data
  • February 24, 2026

Gossamer Bio Reports Mixed Results for Seralutinib in PAH, Demonstrates Strong Efficacy in High-Risk Subgroups Is the current landscape of pulmonary arterial hypertension (PAH) treatments failing to meet the needs…

Read MoreGossamer Bio Announces Topline Results for Phase 3 PROSERA Study of Seralutinib in PAH
Synthekine
  • Regulatory

Synthekine Inc. Appoints John A. Orwin as Board Chair to Lead Clinical Expansion

  • The Pharma Data
  • February 24, 2026

Biotech Leader Takes Helm as Synthekine Advances Phase 2 Cancer Study In the rapidly evolving landscape of biotechnology, where precision and innovation are paramount, Synthekine Inc. is making a strategic…

Read MoreSynthekine Inc. Appoints John A. Orwin as Board Chair to Lead Clinical Expansion
Integrated DNA
  • Research

Integrated DNA Technologies Unveils Next-Generation Sequencing Innovations for Cancer Research

  • The Pharma Data
  • February 24, 2026

IDT Launches Advanced NGS Portfolio to Tackle Key Bottlenecks in Cancer Research As cancer research enters a new era defined by ultra-sensitive identification and rapidly expanding biomarker landscapes, Integrated DNA…

Read MoreIntegrated DNA Technologies Unveils Next-Generation Sequencing Innovations for Cancer Research
  • Press Releases

Atara Biotherapeutics Extends Milestone Payment Deadline to 2028

  • The Pharma Data
  • February 24, 2026

Atara Biotherapeutics Secures Flexibility for Tabelecleucel Development Why is the timing of milestone payments crucial for biotech companies? Atara Biotherapeutics, Inc. a leader in T-cell immunotherapy, has secured an extension…

Read MoreAtara Biotherapeutics Extends Milestone Payment Deadline to 2028
Organon
  • ResearchNews

Organon Expands Women’s Health Portfolio With MIUDELLA Copper IUD

  • The Pharma Data
  • February 24, 2026

Global Healthcare Leader Organon Licenses Sebela Pharmaceuticals’ MIUDELLA for Diverse Reproductive Health Needs Why is the landscape of women’s reproductive health evolving so rapidly? Organon a global healthcare company with…

Read MoreOrganon Expands Women’s Health Portfolio With MIUDELLA Copper IUD
United Therapeutics
  • News

United Therapeutics Corporation to Present at TD Cowen Health Care Conference

  • The Pharma Data
  • February 24, 2026

Michael Benkowitz to Provide Company Overview and Update on March 2, 2026 Why do healthcare conferences matter in the biotech industry? United Therapeutics Corporation a pioneering biotechnology company based in…

Read MoreUnited Therapeutics Corporation to Present at TD Cowen Health Care Conference
Pelage Pharmaceuticals
  • Press Releases

Pelage Pharmaceuticals Strengthens Leadership and Board with Strategic Appointments

  • The Pharma Data
  • February 24, 2026

Pelage Pharmaceuticals Appoints New Board Member and Promotes Key Executives In the competitive landscape of regenerative medicine, where innovative solutions for hair loss are increasingly in demand, Pelage Pharmaceuticals is…

Read MorePelage Pharmaceuticals Strengthens Leadership and Board with Strategic Appointments
Rocket Pharmaceuticals
  • Regulatory

Rocket Pharmaceuticals Advances Rare Disease Treatments With Key Conference Appearances

  • The Pharma Data
  • February 24, 2026

Rocket Pharmaceuticals to Present at Major Healthcare Conferences in Boston and Miami In the rapidly evolving landscape of genetic therapies, where precision and innovation are paramount, Rocket Pharmaceuticals, Inc. is…

Read MoreRocket Pharmaceuticals Advances Rare Disease Treatments With Key Conference Appearances
SylamoreBio
  • Research

SylamoreBio Partners with Daiichi Sankyo to Advance CNS Therapeutics

  • The Pharma Data
  • February 24, 2026

Biotech Pioneer SylamoreBio Collaborates with Daiichi Sankyo to Tackle CNS Delivery Challenges How can biotech companies overcome the formidable barriers to delivering therapies to the central nervous system (CNS)? SylamoreBio,…

Read MoreSylamoreBio Partners with Daiichi Sankyo to Advance CNS Therapeutics
Blackstone
  • News

Blackstone Life Sciences Advances AML Treatment With Bleximenib Funding

  • The Pharma Data
  • February 24, 2026

BXLS and Johnson & Johnson Collaborate to Fund Bleximenib Clinical Trials for AML Why is the development of new treatments for acute myeloid leukemia (AML) so critical? Despite being the…

Read MoreBlackstone Life Sciences Advances AML Treatment With Bleximenib Funding
Bristol Myers Squibb
  • Press Releases

Bristol Myers Squibb Advances Alpha-Thalassemia Treatment With Reblozyl

  • The Pharma Data
  • February 24, 2026

Positive Top-Line Results for Reblozyl in Alpha-Thalassemia Study Is the treatment landscape for alpha-thalassemia about to change? Bristol Myers Squibb has announced positive top-line results from an ongoing, ex-US, Phase…

Read MoreBristol Myers Squibb Advances Alpha-Thalassemia Treatment With Reblozyl
Next
Global Clinical
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • ClearNote Health Launches Enhanced Avantect® Pancreatic Cancer Test
  • Gossamer Bio Announces Topline Results for Phase 3 PROSERA Study of Seralutinib in PAH
  • Synthekine Inc. Appoints John A. Orwin as Board Chair to Lead Clinical Expansion
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.